Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, approved in more than 80 countries worldwide and indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Here, PTGS2 is linked to osteoarthritis.